Unlock stock picks and a broker-level newsfeed that powers Wall Street.
2.6100
+0.2300
+(9.66%)
At close: April 4 at 5:23:54 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Expense
36,144
36,144
38,262
56,569
78,143
Operating Income
-36,144
-36,144
-38,262
-56,569
-78,143
Net Non Operating Interest Income Expense
910
910
1,095
203
145
Pretax Income
-35,234
-35,234
-37,167
-56,239
-77,781
Net Income Common Stockholders
-35,234
-35,234
-37,167
-56,239
-77,781
Diluted NI Available to Com Stockholders
-35,234
-35,234
-37,167
-56,239
-77,781
Basic EPS
-0.44
-0.46
-0.60
-1.05
-1.83
Diluted EPS
-0.44
-0.46
-0.60
-1.05
-1.83
Basic Average Shares
78,573.9810
77,151.5500
62,087.0120
53,822.1940
42,616.3570
Diluted Average Shares
78,573.9810
77,151.5500
62,087.0120
54,222.7900
43,079.0170
Total Operating Income as Reported
-36,144
-36,144
-38,262
-56,442
-77,926
Total Expenses
36,144
36,144
38,262
56,569
78,143
Net Income from Continuing & Discontinued Operation
-35,234
-35,234
-37,167
-56,239
-77,781
Normalized Income
-35,234
-35,234
-37,167
-56,239
-77,781
Interest Income
929
929
1,102
207
146
Interest Expense
19
19
7
4
1
Net Interest Income
910
910
1,095
203
145
EBIT
-35,215
-35,215
-37,160
-56,235
-77,780
EBITDA
-34,922
-34,922
-36,684
-55,665
-77,204
Reconciled Depreciation
293
293
476
570
576
Net Income from Continuing Operation Net Minority Interest
-35,234
-35,234
-37,167
-56,239
-77,781
Normalized EBITDA
-34,922
-34,922
-36,684
-55,665
-77,204
12/31/2021 - 11/28/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
DIABIO.ST Diagonal Bio AB (publ)
0.0145
0.00%
LIDDS.ST LIDDS AB (publ)
0.0600
+55.44%
CHOSA.ST CHOSA Oncology AB
0.6680
-4.57%
SIMRIS-B.ST Simris Group AB (PUBL)
0.1105
-1.34%
2CUREX.ST 2cureX AB (publ)
0.3500
-6.17%
ANNX.ST Annexin Pharmaceuticals AB (publ)
0.3040
-1.62%
LPGO.ST Lipigon Pharmaceuticals AB (publ)
0.1264
+6.94%
IMMU.ST Mendus AB (publ)
5.70
+2.46%
QUIA.ST Quia Pharma AB (publ)
0.0094
+62.07%
XSPRAY.ST Xspray Pharma AB (publ)
26.05
-9.86%